Humalog Mix 25 in the treatment of type 2 diabetes mellitus

Diabetes mellitus type 2 remains one of the most significant chronic diseases. More than 552 million individuals (one of every teninhabitants of the planet) are estimated to have diabetes mellitus to 2030. Early incapacitation and high mortality rates resulting fromlong-term diabetes complications c...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vladimir Ivanovich Zoloedov, Ivan Petrovich Gorshkov, Anna Petrovna Volynkina
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	diabetes mellitus diabetes care insulin therapy Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/6333f429a39b4442a5f22612aeff749b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6333f429a39b4442a5f22612aeff749b
record_format	dspace
spelling	oai:doaj.org-article:6333f429a39b4442a5f22612aeff749b2021-11-14T09:00:17ZHumalog Mix 25 in the treatment of type 2 diabetes mellitus2072-03512072-037810.14341/2072-0351-5520https://doaj.org/article/6333f429a39b4442a5f22612aeff749b2012-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5520https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Diabetes mellitus type 2 remains one of the most significant chronic diseases. More than 552 million individuals (one of every teninhabitants of the planet) are estimated to have diabetes mellitus to 2030. Early incapacitation and high mortality rates resulting fromlong-term diabetes complications constitute social significance of carbohydrate metabolism disorders. Despite modern advances intreatment, most diabetic patients are not adequately compensated, requiring intensification of insulin therapy. Pre-mixed insulins areone of the most advanced options of treatment intensification.Vladimir Ivanovich ZoloedovIvan Petrovich GorshkovAnna Petrovna VolynkinaEndocrinology Research Centrearticlediabetes mellitusdiabetes careinsulin therapyNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 2, Pp 60-63 (2012)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus diabetes care insulin therapy Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus diabetes care insulin therapy Nutritional diseases. Deficiency diseases RC620-627 Vladimir Ivanovich Zoloedov Ivan Petrovich Gorshkov Anna Petrovna Volynkina Humalog Mix 25 in the treatment of type 2 diabetes mellitus
description	Diabetes mellitus type 2 remains one of the most significant chronic diseases. More than 552 million individuals (one of every teninhabitants of the planet) are estimated to have diabetes mellitus to 2030. Early incapacitation and high mortality rates resulting fromlong-term diabetes complications constitute social significance of carbohydrate metabolism disorders. Despite modern advances intreatment, most diabetic patients are not adequately compensated, requiring intensification of insulin therapy. Pre-mixed insulins areone of the most advanced options of treatment intensification.
format	article
author	Vladimir Ivanovich Zoloedov Ivan Petrovich Gorshkov Anna Petrovna Volynkina
author_facet	Vladimir Ivanovich Zoloedov Ivan Petrovich Gorshkov Anna Petrovna Volynkina
author_sort	Vladimir Ivanovich Zoloedov
title	Humalog Mix 25 in the treatment of type 2 diabetes mellitus
title_short	Humalog Mix 25 in the treatment of type 2 diabetes mellitus
title_full	Humalog Mix 25 in the treatment of type 2 diabetes mellitus
title_fullStr	Humalog Mix 25 in the treatment of type 2 diabetes mellitus
title_full_unstemmed	Humalog Mix 25 in the treatment of type 2 diabetes mellitus
title_sort	humalog mix 25 in the treatment of type 2 diabetes mellitus
publisher	Endocrinology Research Centre
publishDate	2012
url	https://doaj.org/article/6333f429a39b4442a5f22612aeff749b
work_keys_str_mv	AT vladimirivanovichzoloedov humalogmix25inthetreatmentoftype2diabetesmellitus AT ivanpetrovichgorshkov humalogmix25inthetreatmentoftype2diabetesmellitus AT annapetrovnavolynkina humalogmix25inthetreatmentoftype2diabetesmellitus
_version_	1718429583652421632

Humalog Mix 25 in the treatment of type 2 diabetes mellitus

Ejemplares similares